Close Menu

NEW YORK – PerkinElmer announced on Monday its test for detecting and differentiating SARS-CoV-2, influenza A/B viruses, and respiratory syncytial virus has received the CE mark.

The PKamp Respiratory SARS-CoV-2 RT-PCR Panel is also being reviewed by the US Food and Drug Administration for Emergency Use Authorization, the Waltham, Massachusetts-based company said. The test is designed to save resources by testing for the four viruses in one test using single nasopharyngeal, oropharyngeal, or nasal swab samples, and is for use with PerkinElmer's automated viral nucleic extractor.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.

A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.

The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.

In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.